NEURO2024

Presentation information

Training School for Next Generation Scientists

[3TS11a] MC and BC, Disease 2

Fri. Jul 26, 2024 2:50 PM - 4:50 PM Room 11 (409)

Senior Discussant: Takahiro Masuda (Medical Institute of Bioregulation, Kyushu University), Norihisa Bizen (Graduate School of Medical and Dental Sciences, Niigata University)
Young Chair: Mami Matsumoto (Department of Developmental and Regenerative Neurobiology, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences)

[3TS11a-02] Spinal cord motor neuron phenotypes and polygenic risk scores in sporadic ALS: deciphering disease pathology and therapeutic potential of ropinirole hydrochloride

*Chris Kato1, Satoru Morimoto1, Shinichi Takahashi1,2, Shinichi Namba3, Qingbo Seiha Wang3,4,5, Yukinori Okada3,4,5,6,7,8, Hideyuki Okano1 (1. Keio University, 2. Department of Neurology and Stroke, Saitama Medical University International Medical Center, 3. Department of Statistical Genetics, Osaka University Graduate School of Medicine, 4. Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, 5. Department of Genome Informatics, Graduate School of Medicine, The University of Tokyo, 6. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 7. Center for Infectious Disease Education and Research (CiDER), Osaka University, 8. Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences)

Keywords:amyotrophic lateral sclerosis, spinal motor neuron, polygenic risk score, ropinirole hydrochloride

Please log in with your participant account.
» Participant Log In